Search Results 331-340 of 38034 for Two-phase

  1. Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer - Mayo Clinic

    Study phase. 3. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  2. Mesothelioma Clinical Trials - Mayo Clinic Research

    This is a Phase 2, multicenter, open-label, 2-part, single-arm, 2-stage study of tazemetostat 800 mg two times a day (BID) administered orally. Screening ...

  3. A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) - Mayo Clinic

    Study phase. 1/2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase ( ...

  4. Clinical trials - Oncology (Medical)

    ... phase 2 dose (RP2D) and preferred schedule, and assess preliminary anti-tumor activity. Patient Outcomes after Hepatic Artery Infusion Pump Placement.

  5. Pacritinib Vs. Hydroxyurea In Advanced Proliferative Chronic Myelomonocytic Leukemia - Mayo Clinic

    Study phase. 2. During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase ...

  6. Skin cancer - Diagnosis and treatment - Mayo Clinic

    Photodynamic therapy is a two-stage treatment that combines light energy with a medicine called a photosensitizer. The photosensitizer kills the cancer ...

  7. Estrogen Receptor Positive Breast Cancer Clinical Trials - Mayo Clinic Research

    A Phase II study to investigate the potential utility of PD 0332991 in the treatment of early stage ER+ Human epidermal growth factor receptor 2 (HER2)- breast ...

  8. A Study of Grapiprant and Pembrolizumab in Patients with Advanced or Progressive MSS Colorectal Cancer - Mayo Clinic

    The purpose of this study is to assess safety and tolerability of grapiprant in combination with pembrolizumab, to determine the recommended phase 2 dose (RP2D) ...

  9. Ovarian Cancer Clinical Trials - Mayo Clinic Research

    To assess the safety and pharmacokinetics (PK) in order to determine a maximally tolerated dose (MTD) or recommended phase 2 dose (RP2D) of REGN4018 as ...

  10. Study Is To Assess The Safety And Tolerability Of VTx-002 In Participants With ALS - Mayo Clinic

    PIONEER-ALS is a Phase 1/2, multicenter, open-label, ascending dose ... Two escalating dose (low dose and high dose) cohorts are planned. The duration ...